Low-dose rituximab in ITP: One and Done.
Sign Up to like & getrecommendations! Published in 2022 at "American journal of hematology"
DOI: 10.1002/ajh.26489
Abstract: Rituximab is a widely-used medication for many years, important in management of immune thrombocytopenia (ITP); however, the optimal rituximab dose remains unknown. Ni and colleagues report a clinical trial comparing 2 doses of rituximab: a… read more here.
Keywords: dose rituximab; dose; itp one; rituximab itp ... See more keywords